te Mankind Pharma IPO receives 87 per cent subscription on Day 2 | Zee Business

Mankind Pharma IPO receives 87 per cent subscription on Day 2

The company has fixed a price band of Rs 1,026-1,080 per share. At the upper end of the price band, the IPO size is estimated at Rs 4,326 crore.

Mankind Pharma IPO receives 87 per cent subscription on Day 2
Mankind Pharma is engaged in developing, manufacturing and marketing a diverse range of pharmaceutical formulations across various acute and chronic therapeutic areas.

The initial share sale of Mankind Pharma has been subscribed 87 per cent on the second day of the offer on Wednesday. The IPO received bids for 2,45,19,352 shares against 2.80 crore shares on offer, according to NSE data.

The category for Qualified Institutional Buyers (QIBs) was subscribed 1.86 times, Non-Institutional Investors portion received 1.02 times subscription and Retail Individual Investors (25 per cent).

The company's IPO is entirely an Offer For Sale (OFS) of 4,00,58,844 equity shares by promoters and other existing shareholders.

TRENDING NOW

Those selling shares in the OFS are promoters Ramesh Juneja, Rajeev Juneja and Sheetal Arora. Besides, Cairnhill CIPEF, Cairnhill CGPE, Beige Limited, and Link Investment Trust will participate in the OFS.

Since the IPO is completely an OFS, the company will not receive any net proceeds from the issue and the entire net proceeds will go to the selling shareholders.

The company has fixed a price band of Rs 1,026-1,080 per share. At the upper end of the price band, the IPO size is estimated at Rs 4,326 crore.

Mankind Pharma is engaged in developing, manufacturing and marketing a diverse range of pharmaceutical formulations across various acute and chronic therapeutic areas, as well as several consumer healthcare products.

Kotak Mahindra Capital Company, Axis Capital, IIFL Securities, Jefferies India and JP Morgan India are the book-running lead managers to the issue.

The equity shares of the company will be listed on May 9 on both the bourses --BSE and NSE.

 

Also Read: Bajaj Finance Q4 results: Net profit rises 30% to Rs 3,158 crore; declares dividend of Rs 30 per share  

Also Read: Maruti Q4: Net profit jumps 42.7% to Rs 2,623.6 crore, firm declares dividend of Rs 90/share

Written By: PTI
Updated: Wed, Apr 26, 2023
08:35 pm
PTI
RELATED NEWS
Anil Singhvi shares his view on Mankind Pharma IPO, calls it a stock worth having in portfolio Anil Singhvi shares his view on Mankind Pharma IPO, calls it a stock worth having in portfolio
Mankind Pharma IPO: Catch subscription update, issue price, lot size, listing date, other key details here Mankind Pharma IPO: Catch subscription update, issue price, lot size, listing date, other key details here
Ahead of IPO, Mankind Pharma mobilizes Rs 1,298 cr from anchor investors Ahead of IPO, Mankind Pharma mobilizes Rs 1,298 cr from anchor investors
From global cues to Mankind Pharma IPO launch, 10 things to know before Street opens today From global cues to Mankind Pharma IPO launch, 10 things to know before Street opens today
Mankind Pharma IPO opens today; should you subscribe to it? Mankind Pharma IPO opens today; should you subscribe to it?

By accepting cookies, you agree to the storing of cookies on your device to enhance site navigation, analyze site usage, and assist in our marketing efforts.

x